Trial reportInternational journal of clinical pharmacy2020
Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Trial report in International journal of clinical pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 6 syntheses or guidelines pooled it, 67 citations in OpenAlex.
- Pooled it
- Impact of pharmacist-led deprescribing interventions on medication related outcomes among older adults: a systematic review and meta-analysis.BMC geriatrics · 2026Pooled it
- Interventions to Address Potentially Inappropriate Prescribing for Older Primary Care Patients: A Systematic Review and Meta-Analysis.JAMA network open · 2025Pooled it
- Withdrawal of antihypertensive drugs in older people.The Cochrane database of systematic reviews · 2025Pooled it
- Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis.International journal of clinical pharmacy · 2023Pooled it
- Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review.BMC geriatrics · 2023Pooled it
- Electronic Decision Support for Deprescribing in Older Adults Living in Long-Term Care: A Stepped-Wedge Cluster Randomized Trial.JAMA network open · 2025Trial
- The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study.BMC geriatrics · 2023Trial
- Deprescribing proton pump inhibitors in long-term care: Outcomes of a pharmacist-led initiative.Exploratory research in clinical and social pharmacy · 2026Article
- Tailoring an Implementation Strategy for Deprescribing as Part of a Comprehensive Geriatric Assessment (dCGA) in Long-Term Care Facilities: A Roundtable Discussion.Basic & clinical pharmacology & toxicology · 2026Article
- Impact of Deprescribing Among Older Adults in Primary Care Settings: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Aging medicine (Milton (N.S.W)) · 2026Review
- The role of pharmacists in geriatric care: current evidence and practice.Aging clinical and experimental research · 2026Review
- Exploring Australian pharmacists' experiences with the electronic National Residential Medication Chart: a qualitative descriptive study.International journal of clinical pharmacy · 2025Article
- A multidisciplinary meeting for generating a personalized pharmaceutical plan for older adults at hospital discharge: the IATROPREV study.British journal of clinical pharmacology · 2025Observational
- Developing a Theoretically Informed Strategy to Enhance Pharmacist-Led Deprescribing in Care Homes for Older People.Pharmacy (Basel, Switzerland) · 2025Article
- The Impact of a Community Pharmacy-Led Deworming-Related Counselling Service: An Interventional Study in a Low-to-Middle Income Country.Tropical medicine and infectious disease · 2025Article
- Article
- Pharmacist-Mediated Deprescribing in Long-Term Care Facilities: A Systematic Review.Pharmacy (Basel, Switzerland) · 2025Review
- Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions: MoPIM cohort study.BMC geriatrics · 2024Article
- Measuring Quality of Life in Deprescribing Trials: A Scoping Review.Drugs & aging · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Polypharmacy is prevalent among long-term care residents in Canada, with 48.4% receiving ten or more different medications and 40.7% chronically prescribed potentially inappropriate medications. Objective We implemented a pharmacist-administered deprescribing program in a long-term care facility to determine if the number of medications taken per resident could be reduced.
settingA long-term care facility in Newfoundland and Labrador, Canada from February 2017 to February 2018.
methodResidents were randomized to receive either a deprescribing-focused medication review by a pharmacist or usual care. Main outcome measure Change in the number of medications at 3 and 6 months. Results Forty-five residents enrolled in the study (n = 22 intervention, n = 23 control). Seventy-eight deprescribing recommendations were made, and 85.1% were successfully implemented. The average number of medications taken by residents in the intervention group was 2.68 less than the control group (p < 0.02; 95% CI - 4.284, - 1.071) at 3 months and 2.88 less (p = 0.02, 95% CI - 4.543, - 1.112) at 6 months. In 14.9% of cases, a medication had to be restarted after deprescribing was attempted because symptoms returned.
conclusionA pharmacist-led deprescribing intervention can reduce the number of unnecessary and potentially harmful medications taken by LTC residents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.